Catalyst Pharmaceuticals

+$0.01 (+0.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.

About CPRX

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E.

CEO
Patrick J. McEnany
Employees
74
Headquarters
Coral Gables, Florida
Founded
2002

CPRX Key Statistics

Market Cap
603.65M
Price-Earnings Ratio
8.60
Dividend Yield
—
Average Volume
627.35K
High Today
$5.89
Low Today
$5.75
Open Price
$5.78
Volume
514.54K
52 Week High
$6.22
52 Week Low
$2.88

CPRX Earnings

$0.00
$0.04
$0.09
$0.13
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure